Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
December 5, 2017
Spago Nanomedical

Spago Nanomedical select ChemConnection for SpagoPix production to supply clinical trials

Spago Nanomedical AB has signed an agreement with ChemConnection BV, a well-established contract manufacturer with extensive experience in the GMP-production of nanomedical products, for the manufacture of the SpagoPix product candidate SN132D for clinical trials.

Spago Nanomedical select ChemConnection for SpagoPix production to supply clinical trials

Spago Nanomedical AB has signed an agreement with ChemConnection BV, a well-established contract manufacturer with extensive experience in the GMP-production of nanomedical products, for the manufacture of the SpagoPix product candidate SN132D for clinical trials.

Spago Nanomedical AB has signed an agreement with ChemConnection BV, a well-established contract manufacturer with extensive experience in the GMP-production of nanomedical products, for the manufacture of the SpagoPix product candidate SN132D for clinical trials.

The SpagoPix project is advancing towards clinical trials and the product candidate SN132D is currently undergoing regulatory preclinical tests to generate the toxicity and safety data required to initiate human studies.

The production of material will commence in the first half of 2018. Tech transfer in which Spago Nanomedical transfers the production process developed by the company during the past year, starts immediately.

“We look forward to starting the GMP production of SN132D and continue preparations for clinical trials,” says Oskar Axelsson, CSO of Spago Nanomedical.

“We are proud that we can contribute to the development of this exciting new product with the manufacture of clinical batches” says Gerjan Kemperman, CEO of ChemConnection.

 

For further information, contact Mats Hansen, CEO Spago Nanomedical AB, +46 767 764294, 
mats.hansen@spagonanomedical.se.

 

PDF: Spago Nanomedical select ChemConnection for SpagoPix production to supply clinical trials

Last updated:
December 5, 2017

Spago Nanomedical

Spago Nanomedical AB is a Swedish company performing research and development within nanomedicine. Focus is the development of nanomaterials for tumor diagnostics and treatment of cancer. The main development projects SpagoPix and Tumorad are both built on proprietary nanomaterials

Click here to read more about us!
Get in touch with us!
Visit us

Scheelevägen 22
SE-223 63 Lund
Sweden

Send us mail

Spago Nanomedical AB has signed an agreement with ChemConnection BV, a well-established contract manufacturer with extensive experience in the GMP-production of nanomedical products, for the manufacture of the SpagoPix product candidate SN132D for clinical trials.

The SpagoPix project is advancing towards clinical trials and the product candidate SN132D is currently undergoing regulatory preclinical tests to generate the toxicity and safety data required to initiate human studies.

The production of material will commence in the first half of 2018. Tech transfer in which Spago Nanomedical transfers the production process developed by the company during the past year, starts immediately.

“We look forward to starting the GMP production of SN132D and continue preparations for clinical trials,” says Oskar Axelsson, CSO of Spago Nanomedical.

“We are proud that we can contribute to the development of this exciting new product with the manufacture of clinical batches” says Gerjan Kemperman, CEO of ChemConnection.

 

For further information, contact Mats Hansen, CEO Spago Nanomedical AB, +46 767 764294, 
mats.hansen@spagonanomedical.se.

 

PDF: Spago Nanomedical select ChemConnection for SpagoPix production to supply clinical trials

Last updated:
December 5, 2017

Spago Nanomedical

Spago Nanomedical AB is a Swedish company performing research and development within nanomedicine. Focus is the development of nanomaterials for tumor diagnostics and treatment of cancer. The main development projects SpagoPix and Tumorad are both built on proprietary nanomaterials

Click here to read more about us!
Get in touch with us!
Visit us

Scheelevägen 22
SE-223 63 Lund
Sweden

Send us mail